
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18056519
[patent_doc_number] => 20220387605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION
[patent_app_type] => utility
[patent_app_number] => 16/632226
[patent_app_country] => US
[patent_app_date] => 2018-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632226 | COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION | Jul 17, 2018 | Pending |
Array
(
[id] => 13793031
[patent_doc_number] => 20190010054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => SELF ASSEMBLING BETA-BARREL PROTEINS POSITION NANOTUBES
[patent_app_type] => utility
[patent_app_number] => 16/038084
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16038084
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/038084 | Self assembling beta-barrel proteins position nanotubes | Jul 16, 2018 | Issued |
Array
(
[id] => 16204935
[patent_doc_number] => 20200237925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => POLYPEPTIDE EYE ABSORPTION ENHANCER AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/618915
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618915 | Polypeptide eye absorption enhancer and use thereof | Jul 12, 2018 | Issued |
Array
(
[id] => 19121034
[patent_doc_number] => 11965004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Molecular guide system peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/629799
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 31
[patent_no_of_words] => 10645
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629799 | Molecular guide system peptides and uses thereof | Jul 9, 2018 | Issued |
Array
(
[id] => 16156523
[patent_doc_number] => 20200216494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => A METHOD OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/624367
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624367 | Method of treatment | Jun 28, 2018 | Issued |
Array
(
[id] => 17649675
[patent_doc_number] => 11352389
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Treatment of haematological malignancies
[patent_app_type] => utility
[patent_app_number] => 16/627230
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 42
[patent_no_of_words] => 31097
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627230 | Treatment of haematological malignancies | Jun 27, 2018 | Issued |
Array
(
[id] => 15963121
[patent_doc_number] => 20200165312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/627116
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627116 | COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE | Jun 27, 2018 | Abandoned |
Array
(
[id] => 14913613
[patent_doc_number] => 10428113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
[patent_app_type] => utility
[patent_app_number] => 16/022306
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 25
[patent_no_of_words] => 20350
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16022306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/022306 | Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions | Jun 27, 2018 | Issued |
Array
(
[id] => 13476629
[patent_doc_number] => 20180289857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => COMPOSITE COLLAGEN HYDROGEL MATERIAL, AN IMPLANTABLE OPHTHALMIC DEVICE COMPRISING SUCH MATERIAL AND METHODS OF PRODUCING THE COMPOSITE COLLAGEN HYDROGEL MATERIAL AND THE IMPLANTABLE OPHTHALMIC DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/003424
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003424 | Composite collagen hydrogel material, an implantable opthalmic device comprising such material and methods of producing the composite collagen hydrogel material and the implantable ophthalmic device | Jun 7, 2018 | Issued |
Array
(
[id] => 18349451
[patent_doc_number] => 20230137562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => TAU AGGREGATION INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/615026
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615026 | TAU AGGREGATION INHIBITORS | Jun 6, 2018 | Abandoned |
Array
(
[id] => 15513287
[patent_doc_number] => 10563221
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Insecticidal proteins and methods for their use
[patent_app_type] => utility
[patent_app_number] => 16/001133
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 107177
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16001133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/001133 | Insecticidal proteins and methods for their use | Jun 5, 2018 | Issued |
Array
(
[id] => 13622883
[patent_doc_number] => 20180362993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => ELICITOR-DERIVED PEPTIDES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/989647
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989647 | ELICITOR-DERIVED PEPTIDES AND USE THEREOF | May 24, 2018 | Abandoned |
Array
(
[id] => 15071407
[patent_doc_number] => 10465180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Factor IX polypeptide mutant, its uses and method for its production
[patent_app_type] => utility
[patent_app_number] => 15/989665
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11935
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989665 | Factor IX polypeptide mutant, its uses and method for its production | May 24, 2018 | Issued |
Array
(
[id] => 15931035
[patent_doc_number] => 20200157151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/616098
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616098 | PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES | May 23, 2018 | Abandoned |
Array
(
[id] => 15420657
[patent_doc_number] => 10543231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Methods and materials for treating cancer
[patent_app_type] => utility
[patent_app_number] => 15/981656
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10104
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981656
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981656 | Methods and materials for treating cancer | May 15, 2018 | Issued |
Array
(
[id] => 20385448
[patent_doc_number] => 12485158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Norrin induced expression of genes and use thereof to treat disease
[patent_app_type] => utility
[patent_app_number] => 16/611063
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 4702
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611063
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611063 | Norrin induced expression of genes and use thereof to treat disease | May 6, 2018 | Issued |
Array
(
[id] => 15931105
[patent_doc_number] => 20200157186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => TRUNCATED VWF
[patent_app_type] => utility
[patent_app_number] => 16/610701
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610701 | Truncated VWF | May 3, 2018 | Issued |
Array
(
[id] => 16452564
[patent_doc_number] => 20200361990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => POLYPEPTIDE HAVING ANALGESIC ACTIVITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/762948
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762948 | Polypeptide having analgesic activity and use thereof | May 1, 2018 | Issued |
Array
(
[id] => 15960561
[patent_doc_number] => 20200164032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => CHEMOKINE DECOY RECEPTORS OF RODENT GAMMAHERPESVIRUSES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/608672
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608672
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608672 | Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof | Apr 26, 2018 | Issued |
Array
(
[id] => 18341270
[patent_doc_number] => 11638739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Inhibition of TREM receptor signaling with peptide variants
[patent_app_type] => utility
[patent_app_number] => 15/962589
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23783
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962589
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962589 | Inhibition of TREM receptor signaling with peptide variants | Apr 24, 2018 | Issued |